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ABSTRACT CKS proteins are small (9-kDa) polypeptides that bind to a subset of the
cyclin-dependent kinases. The two paralogs expressed in mammals, Cks1 and Cks2,
share an overlapping function that is essential for early development. However, both
proteins are frequently overexpressed in human malignancy. It has been shown that
CKS protein overexpression overrides the replication stress checkpoint, promoting
continued origin ﬁring. This ﬁnding has led to the proposal that CKS protein-dependent
checkpoint override allows premalignant cells to evade oncogene stress barriers,
providing a causal link to oncogenesis. Here, we provide mechanistic insight into how
overexpression of CKS proteins promotes override of the replication stress check-
point. We show that CKS proteins greatly enhance the ability of Cdk2 to phosphory-
late the key replication initiation protein treslin in vitro. Furthermore, stimulation of
treslin phosphorylation does not occur by the canonical adapter mechanism demon-
strated for other substrates, as cyclin-dependent kinase (CDK) binding-defective mu-
tants are capable of stimulating treslin phosphorylation. This effect is recapitulated
in vivo, where silencing of Cks1 and Cks2 decreases treslin phosphorylation, and
overexpression of wild-type or CDK binding-defective Cks2 prevents checkpoint-
dependent dephosphorylation of treslin. Finally, we provide evidence that the role
of CKS protein-dependent checkpoint override involves recovery from checkpoint-
mediated arrest of DNA replication.
KEYWORDS CKS protein, treslin, treslin phosphorylation, replication stress
checkpoint, checkpoint recovery
CKS proteins were discovered in budding yeast and ﬁssion yeast based on geneticinteractions with CDK1 mutants (cdc28 in budding yeast and cdc2 in ﬁssion yeast)
(1, 2). Based on homology, similar proteins were identiﬁed in a variety of eukaryotes,
including two paralogs in vertebrates, Cks1 and Cks2 (3). Although these small con-
served proteins were shown, shortly after their discovery, to bind to a subset of
cyclin-dependent kinases (CDKs) (4), their function(s) remained obscure until recently.
The crystallographically determined geometry of Cks1 bound to Cdk2 suggested an
adaptor function, promoting targeting of the kinase to substrates (5). The fact that CKS
proteins possess a phosphate binding site has led to the hypothesis that CKS proteins
can tether CDKs to substrates already primed by phosphorylation for efﬁcient subse-
quent multiphosphorylation. Indeed, this mechanism has been borne out for some
substrates, such as the yeast CDK inhibitors Sic1 and Far1 (6, 7), and is probably the case
for a variety of other CDK substrates in vertebrates, such as Cdc27, Cdc25, Wee1, and
Myt1 (8, 9). However, a number of other well-characterized adapter functions have
been attributed to CKS proteins, all presumably stemming from their ability to form
relatively high-afﬁnity complexes with CDKs. CKS proteins are critical for efﬁcient
docking of Cdk2-cyclin A complexes to the ubiquitin ligase anaphase-promoting
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complex/cyclosome (APC/C) for the metaphase ubiquitin-dependent proteolysis of
cyclin A (10). The paralog Cks1 is essential for the binding of the SCF ubiquitin ligase
speciﬁcity factor Skp2 to the CDK-bound inhibitor p27Kip1 for ubiquitylation and
degradation (11, 12). Perhaps the most unexpected roles for CKS proteins are in the
realm of transcriptional regulation. In budding yeast, it was found that the Cks1-Cdk1
complex has a kinase-independent role in nucleosome eviction during rapid transcrip-
tional induction (13, 14). This function requires the Paf1 elongation complex and the
19S proteasome particle (15). In mammalian cells, the essential redundant function of
Cks1 and Cks2 is the expression of mRNAs encoding Cdk1, cyclin B1, and cyclin A2 (16).
Although the molecular mechanism remains to be elucidated, it may involve a chro-
matin remodeling function analogous to what has been observed in yeast.
In addition to their normal cellular roles, CKS proteins are likely to have roles in
oncogenesis. Cks1 and/or Cks2 are frequently overexpressed in a broad spectrum of
malignancies (17–30). It has been hypothesized that Cks1 overexpression is linked to its
role in degradation of the CDK inhibitor p27Kip1, as low p27 levels have been associated
with aggressive malignancy in various types of cancer. However, attempts to correlate
high Cks1 levels with low p27 levels in tumors have given mixed results (31–33).
Another potential insight into the role of Cks proteins in oncogenesis comes from
the observation that Cks1 or Cks2, when overexpressed, overrides the replication stress
checkpoint (34). Whereas triggering of the replication stress checkpoint normally
prevents subsequent replication origin ﬁring, cells overexpressing either Cks1 or Cks2
continue to ﬁre origins, even though checkpoint signaling is intact. This observation led
us to speculate that CKS protein overexpression allows premalignant cells to evade
DNA damage checkpoint barriers triggered as the ﬁrst line of defense in response to
activated or overexpressed oncoproteins. Indeed, we observed that there was a strong
correlation in breast tumors between overexpression of cyclin E (34), an oncoprotein
that causes replication stress, and either Cks1 or Cks2. The replication stress checkpoint
detects single-stranded DNA resulting from stalled or collapsed replication forks and
signals to Cdk2 by promoting the degradation of the CDK phosphatase CDC25A
(35–37). As a result, Cdk2 accumulates in its tyrosine 15-phosphorylated inactive form
(38). The link between Cdk2 activity and origin ﬁring is likely to be the protein treslin
(39, 40). The assembly of an active replicative helicase requires the CDK-dependent
phosphorylation of treslin on serine 1000 (S1000). Phosphorylated treslin then binds to
BRCT domains I and II of the protein TopBP1, leading to the recruitment of the initiator
protein Cdc45. This is a highly conserved pathway, where in yeast Sld3 the treslin
ortholog binds to Dbp11, the TopBP1 ortholog, in a CDK-dependent manner to initiate
replication (41, 42). Checkpoint-mediated inhibition of Cdk2 presumably leads to
reversal of these events, precluding subsequent origin ﬁring.
Since CKS protein overexpression permits origin ﬁring in the context of an active
replication stress checkpoint, we sought to determine if there is a link between CKS
protein function and treslin phosphorylation. We found that both Cks1 and Cks2 greatly
enhance the efﬁciency of treslin phosphorylation by Cdk2 in vitro in a reconstituted
reaction using puriﬁed proteins as well as in cultured cells. Interestingly, the stimulation
of treslin phosphorylation does not occur by a mechanism whereby the CKS protein
serves as a canonical CDK substrate adapter, as previously reported, but rather by
improving the efﬁciency of CDK-treslin interaction either by remodeling treslin or by
serving as a noncanonical Cdk2 adapter. Furthermore, we provide evidence that the
function of CKS-enhanced phosphorylation of treslin entails recovery from the replica-
tion stress checkpoint.
RESULTS
Both Cks1 and Cks2 stimulate phosphorylation of treslin by Cdk2. In order to
determine whether Cks1 and/or Cks2 has a role in treslin phosphorylation on serine
1000 (S1000), we developed an in vitro system using puriﬁed proteins. As a surrogate
substrate for treslin, we used a glutathione S-transferase (GST) fusion to a 23-amino-
acid (aa) treslin peptide centered around S1000 [aa 989 to 1011; termed treslin
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(989-1011)] (40) (Fig. 1A). We puriﬁed active cyclin E-Cdk2 from an Escherichia coli strain
that also expresses the yeast Cak1 kinase, which phosphorylates the CDK T-loop-
producing active enzyme (43). Cks1 and Cks2 were also puriﬁed from E. coli. Phosphor-
ylation of the treslin substrate after incubation with Cdk2 was detected using a
phosphoepitope-speciﬁc antibody (40). GST-treslin and Cks1/2 were detected by amido
black staining of blots. Cyclin E-Cdk2 was capable of phosphorylation of the treslin
peptide without any additional proteins. However, addition of Cks1 or Cks2 stimulated
treslin phosphorylation by 10- to 20-fold (Fig. 1B and C). Cks1 also stimulated phos-
phorylation of a larger treslin polypeptide fused to GST (aa 893 to 1257) (Fig. 1D) (40).
In order to rule out that the stimulation of treslin peptide phosphorylation was due to
an interaction between CKS protein and the GST tag, we carried out a parallel
experiment using a pure synthetic peptide [treslin (997-1008)] and determined the
degree of phosphorylation by mass spectroscopy (MS). Cks1 increased phosphorylation
of this peptide by Cdk2 by 10-fold (Fig. 2), similar to what was observed using GST
fusion and Western blotting. Therefore, CKS proteins stimulate treslin peptide phos-
phorylation by interacting directly with treslin sequences.
Dose-dependent phosphorylation of treslin peptide. A kinase assay, as described
above, was performed with Cks1 concentrations ranging from 1.85 nM to 3.7 M (Fig.
3A). The reaction mixture concentrations of Cdk2 and GST-treslin peptide were 17 nM
and 1.1 M, respectively. As can be seen in Fig. 3A, the phosphorylation of treslin
peptide saturates at stoichiometry of Cks1 approximately equivalent to that of GST-
treslin peptide and well in excess of that of Cdk2. On the other hand, the 50% effective
concentration (EC50) of Cks1-mediated stimulation of treslin phosphorylation is 90 nM
(Fig. 3B), similar to the previously determined dissociation constant (Kd) of Cks1 binding
to Cdk2 (77 nM) (5). Therefore, these data are consistent with Cks1 functioning through
binding to Cdk2 or as a stoichiometric substrate adapter. In order to investigate this
ﬁnding further, we determined the smallest treslin peptide capable of CKS protein-
stimulated phosphorylation. An 8-amino-acid peptide (aa 997 to 1004) fused to GST
exhibited CKS-enhanced phosphorylation similar to that of treslin (989-1011) (Fig. 3C).
Considering that Cks1 has been shown to bind to the C-lobe of Cdk2 distal from the
A             Treslin(989-1011):  DPGPDIGVVEESPEKGDEIGLRR
B -EK2 +EK2 +EK2
-Cks1 -Cks1+Cks1 (1.85 µM)   
pS1000
GST-Treslin(989-1011)
Cks1
C   -     Cks1  Cks2
pS1000
GST-Treslin(989-1011)
Cks1/2 (3.7µM)
D pS1000
GST-Treslin(893-1257)
FIG 1 Cks1 and Cks2 stimulate treslin phosphorylation in vitro. (A) GST-treslin substrate. A 23-amino-acid
peptide centered around treslin S1000 fused to GST was used as a Cdk2 substrate for most in vitro
phosphorylation experiments described. (B) Stimulation of GST-treslin phosphorylation by Cks1. In vitro
kinase reactions were carried out using a 23-amino-acid peptide ﬂanking the S1000 phosphorylation site
of treslin fused to GST. Each 30-l reaction mixture contained 17 nM recombinant cyclin E/Cdk2, 1.1 M
GST-treslin, and the indicated concentration of Cks1. Phosphorylation of the treslin substrate was
detected after SDS-PAGE and Western blotting using an antibody that recognizes phosphorylated S1000
of treslin. Cks1 and GST-treslin were detected by amido black staining. (C) Cks1 and Cks2 both stimulate
phosphorylation of GST-treslin. Reaction mixtures like those described for panel B were set up with 3.7
M Cks1 or Cks2. (D) Cks1 stimulates Cdk2-mediated phosphorylation of a larger fragment of treslin
fused to GFP (aa 893 to 1257). Reaction mixtures were like those described for panel B but with 0.185
M Cks1.
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active site (5), it would be impossible for an 8-amino-acid peptide with an internal
phosphorylation site to bind simultaneously to the active site and to CDK-bound Cks1.
We then carried out an experiment to determine whether Cks1 or Cks2 could form a
complex directly with treslin in the absence of Cdk2. Thermal shift analysis was carried
out on CKS protein-treslin peptide mixtures. Incubation with synthetic treslin peptide
FIG 2 Cks1 enhances phosphorylation of a small synthetic treslin peptide. Kinase reactions were as described in the legend to Fig. 1. A synthetic peptide
corresponding to treslin amino acids 997 to 1008 was incubated with buffer only, with cyclin E-Cdk2 alone, or with cyclin E-Cdk2 and Cks1 (1.1 M). The three
mixtures were infused into an Orbitrap mass spectrometer using the ESI method, and both MS1 and MS2 were recorded. MS peaks representing unmodiﬁed
peptide and phosphopeptide are indicated.
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FIG 3 CKS proteins stimulate treslin phosphorylation by a noncanonical mechanism. (A) Dose-dependent Cks1
stimulation of GST-treslin (989-1011) phosphorylation. The kinase assay was performed as described in the legend
to Fig. 1. Cks1 concentrations ranged from 1.85 nM (left) to 3.7 M (second from the right). The area on the far right
has no Cks1. (B) Quantiﬁcation of data shown in panel A using Image J and GraphPad Prism software. arb, arbitrary;
conc, concentration. (C) CKS proteins stimulate phosphorylation of 8-amino-acid peptides ﬂanking the treslin S1000
phosphorylation site. GST fusions corresponding to 23-, 12-, 10-, and 8-amino-acid treslin peptides were incubated
with Cks1 or Cks2, as indicated, and cyclin E/Cdk2 as described in the legend to Fig. 1. The lane on the far right
corresponds to a reaction without CKS protein.
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in buffer used for kinase reactions reproducibly altered the thermal melting curve of
Cks2 by 1.14°C (P  0.002 by single-tailed t test) (Fig. 4A), indicating direct interaction.
A small thermal shift that did not achieve signiﬁcance was observed for Cks1 under the
same conditions at the maximum treslin peptide concentration permissible for the
assay (25 M). However, a thermal shift was observed using different buffer conditions
(data not shown due to lack of relevance to the kinase assay). The thermal shift assay
was then used to determine an approximate Kd (16 M) for treslin peptide binding to
Cks2 (Fig. 4B). This weak interaction is not consistent with the EC50 determined for
CKS-dependent stimulation of treslin phosphorylation (90 nM) and suggests a mech-
anism more complex than simple binding to and remodeling of the phosphorylation
site on treslin (see Discussion).
Neither canonical CDK binding nor phosphate binding is required for stimu-
lation of treslin phosphorylation. In order to conﬁrm that CDK binding is not
important for stimulation of treslin phosphorylation by Cdk2, we compared stimulation
by wild-type Cks2 and a mutant (Cks2 E63Q) previously shown to be defective in CDK
binding (Fig. 5A). There was no defect in stimulation of treslin phosphorylation at high
concentrations of Cks2 E63Q and a slight defect at low concentrations. To conﬁrm that
the E63Q mutation prevents binding to CKS proteins, we carried out a pulldown
experiment using Flag-Cks1 and Flag-Cks1 E63Q with anti-Flag beads. Cyclin E-Cdk2
was retained on the beads only if mixed with wild-type Cks1 but not with Cks1 E63Q
(Fig. 5B). Although not apparent in Fig. 5B, it has been shown that the mutant paralog
Cks2 E63Q has a residual, extremely weak afﬁnity for Cdk2 based on surface plasmon
resonance measurements (44). Therefore, we combined the E63Q mutation with an-
other mutation shown to completely eliminate CDK binding (45), creating the double
mutant Cks1 E63Q H60A. Figure 5C compares wild-type Cks1, Cks1 E63Q, Cks1 H60A,
and Cks1 E63Q H60A at 1.85 M for ability to stimulate treslin phosphorylation. As is
evident, all mutants are indistinguishable from the wild type, indicating that canonical
Cdk2 binding is not required for stimulation of treslin phosphorylation. To rule out that
stimulation of treslin phosphorylation is simply a function of protein concentration in
the reaction mixture, 10 g/ml bovine serum albumin (equivalent to 1.1 M CKS
protein) was substituted for CKS protein (Fig. 5A). No stimulation of treslin phosphor-
ylation was observed.
Since the GST-treslin peptide contains only one CDK phosphorylation site, it was
unlikely that a phosphate binding mutant would affect phosphorylation unless these
residues are directly involved in treslin binding by another mechanism. Consistent with
this expectation, a triple mutant (K11E, S51E, R71A) shown to abolish phosphate
binding (5) was not defective in stimulation of GST-treslin peptide phosphorylation
(Fig. 5D).
FIG 4 Cks2 binds weakly to treslin in the absence of Cdk2. (A) Derivatives of melting curves of Cks2 alone and Cks2 with 25
M treslin (997-1008) peptide in kinase buffer. The peak of the derivative curve corresponds to the Tm. (B) Determination of
the Kd of treslin peptide for Cks2 binding by alteration of the Cks2 melting curve. Tm values were determined using the
indicated concentrations of treslin (997-1008) peptide. Treslin (997-1008) alone produces no signal in this assay. Average values
(n  8) were plotted and analyzed using GraphPad Prism. Error bars correspond to SD.
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Cks1 and Cks2 alter the Km of the treslin phosphorylation reaction. If CKS
protein functions to improve the ability of treslin to interact productively with Cdk2,
then it should reduce the Km of the reaction. We therefore determined the Km for treslin
in the absence of CKS protein versus that in the presence of saturating concentrations
of Cks1 or Cks2. For this experiment, mutant protein defective in CDK binding (E63Q)
was used to ensure that effects observed would be related to interactions with treslin
rather than Cdk2. Without CKS protein in the reaction, we could not observe saturation
at concentrations that were permissible in the reaction (Fig. 6). However, in the
presence of Cks1 or Cks2, saturation was approached and Kms could be determined by
curve ﬁtting (59 M for Cks1 and 16 M for Cks2) (Fig. 6). The lower Km in the presence
of Cks2 compared to Cks1 is consistent with the apparent lower afﬁnity of Cks1 for
treslin based on the thermal shift experiments. These data suggest that CKS protein
binding improves the efﬁciency of treslin association with Cdk2, although a simple
A
  0     0.28 0.56 1.1 0.28 0.57 1.1 µM
Cks2-E63Q        Cks2-wt    BSA (10 µg/ml)
pS1000
GST-Treslin(989-1011)
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3% unbound                  Eluate
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(1.85 µM)
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-      wt    AN      -      wt     AN
0.11µM
pS1000
0.37µM
GST-Treslin(989-1011)Cks1
FIG 5 CKS mutants defective in CDK binding and phosphate binding can still stimulate treslin phosphorylation. (A) Cks2 E63Q,
shown to be defective in CDK binding, is not defective in stimulating GST-treslin (989-1011) phosphorylation. Reactions and
analysis were carried out as described in the legend to Fig. 1. Concentrations of wild-type and mutant Cks2 are indicated. The
last lane contains 300 ng (10 g/ml) of bovine serum albumin, conﬁrming the lack of a nonspeciﬁc carrier protein effect. wt,
wild type. (B) Cks1 E63Q is defective in binding to Cdk2. Cyclin E-Cdk2 was incubated with anti-Flag epitope (M2) beads alone
or in the presence wild-type or mutant (E63Q) Flag-tagged Cks1. Beads were then washed and incubated with 3 Flag peptide
to elute bound Flag-Cks1 and associated proteins. Eluates were analyzed by SDS-PAGE and proteins revealed by Coomassie
blue staining. Lanes on the left correspond to supernatant after removal of beads. (C) A CDK binding null mutant of Cks1
containing 2 individual point mutations is not defective in stimulating treslin phosphorylation. The assay was carried out as
described in the legend to Fig. 1. (D) A Cks1 mutant defective in anion binding (AN) is competent to stimulate treslin
phosphorylation. A triple mutant defective in anion (phosphate) binding (K11E, S51E, R71A) was compared to wild-type Cks1
using the assay described in the legend to Fig. 1.
FIG 6 Determination of the Km for treslin phosphorylation in the presence and absence of CKS proteins. Saturation curves for cyclin E-Cdk2 phosphorylation
of GST-treslin in the absence of CKS proteins or in the presence of 25 M Cks1 or Cks2 is shown. The Km was determined by curve ﬁtting using GraphPad Prism
software. Error bars correspond to SD.
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model of CKS protein binding to treslin prior to interaction with Cdk2 is inconsistent
with the determined Kd (see Discussion).
CKS protein function is important for treslin phosphorylation in cells. To
determine whether CKS proteins have a role in treslin phosphorylation in cells, as
suggested by the biochemical studies described above, we silenced Cks1, Cks2, or both
Cks1 and Cks2 simultaneously in HeLa cells using RNA interference (RNAi) technology.
Extracts were separated by SDS-PAGE under conditions designed to resolve high-
molecular-mass proteins such as treslin (apparent molecular mass of 230 kDa). Upon
immunoblotting using these conditions, treslin resolves into several species corre-
sponding to different phosphorylation states (46). In most cases, phosphorylation
confers lower mobility to proteins. Accordingly, silencing of Cks1 or Cks2 modestly
shifted the array of treslin species to higher mobility (Fig. 7A). However, simultaneous
silencing of both Cks1 and Cks2 produced a much more signiﬁcant mobility shift (Fig.
7A). These data suggest that Cks1 and Cks2 contribute to treslin phosphorylation in
cycling cells. However, treslin is a large protein with numerous CDK consensus potential
phosphorylation sites, and a shift in mobility does not directly indicate the phosphor-
ylation status of S1000, the key site for origin ﬁring (40). We therefore carried out an
experiment to directly assess the phosphorylation status of treslin S1000. Extracts
prepared from control HeLa cells and HeLa cells silenced for Cks1 and Cks2 were
immunoprecipitated with antitreslin and anti-phospho-S1000 antibodies, respectively,
and precipitates were subjected to SDS-PAGE and immunoblotting using antitreslin
antibody. Comparing the ratio of treslin p-S1000 to total treslin immunoprecipitated
indicated that silencing of Cks1 and Cks2 led to an70% reduction in phosphorylation
of treslin on S1000 (P  0.0076 by single-tailed t test) (Fig. 7C). Binding of TopBP1 can
also serve as an indicator for treslin S1000 phosphorylation (40). We therefore analyzed
the amount of TopBP1 coprecipitated with total treslin. As with S1000 phosphorylation,
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FIG 7 Silencing of CKS proteins leads to reduced phosphorylation of treslin in cells. (A) siRNA-mediated silencing of Cks1, Cks2, or both leads to
increased mobility of treslin in SDS-PAGE. HeLa cells were transfected with siRNAs corresponding to GFP (control), Cks1, Cks2, or a mixture of Cks1
and Cks2 siRNAs. Cells were harvested after 24 h and extracts analyzed by long runs on 3 to 8% polyacrylamide gels to resolve differentially
phosphorylated species of treslin. Treslin was detected after blotting using antitreslin antibody. Arrows indicate the three most predominant
treslin species. (B) Flow-cytometric analysis of HeLa cells 24 h after siRNA transfection. (C) siRNA-mediated silencing of Cks1 and Cks2 leads to
a reduction in treslin S1000 phosphorylation and TopBP1 binding to treslin. HeLa cells were transfected with siRNAs corresponding to GFP
(control) and both Cks1 and Cks2. Twenty-four hours later, extracts were prepared and immunoprecipitated (IP) with either treslin antibody or
treslin phospho-S1000 antibody. Immunoprecipitates were analyzed by SDS-PAGE and immunoblotting as indicated. TopBP1 and treslin were
analyzed on the same blot by serial incubation with TopBP1 and treslin antibodies. The bar graph corresponds to quantiﬁcation of three
independent biological experiments. “rel p-Tres” and “rel TopBP1” refer to the ratios of phosphotreslin and TopBP1 to total treslin, respectively.
Error bars represent SD. (Left) Extracts were also analyzed for the indicated proteins by immunoblotting. Glyceraldehyde phosphate dehydro-
genase (GAPDH) represents the loading control.
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silencing of Cks1 and Cks2 produced an 70% reduction in TopBP1 binding to treslin
(P  0.005 by single-tailed t test) (Fig. 7C). Based on levels of cyclins E and A in the
lysates (Fig. 7C), which were comparable between control and Cks1/2-silenced samples,
it is unlikely that differences in treslin S1000 phosphorylation can be attributed to a
reduction in Cdk2 kinase activity resulting from CKS silencing. In addition, after a 24-h
interval of silencing of Cks1 and Cks2, there is no signiﬁcant change in the cell cycle
distribution of the population relative to that of asynchronous controls (Fig. 7B).
CKS protein overexpression prevents dephosphorylation of treslin in response
to the replication stress checkpoint. CKS protein overexpression overrides the rep-
lication stress checkpoint. We hypothesized that this is due to an inability to dephos-
phorylate treslin in the presence of high levels of either Cks1 or Cks2. To test this
possibility, we compared control HeLa cells to HeLa cells overexpressing Cks2. We
employed Cks2 in these experiments because, unlike Cks1, Cks2 is not involved in
the SCF-dependent turnover of CDK inhibitors. Thus, any results attributable to Cks2
overexpression are unlikely to be a result of changes in the levels of CDK inhibitors. The
replication stress checkpoint was triggered, as indicated by phosphorylation of Chk1
(Fig. 8), by incubating cells in 2 mM thymidine for 1 h. Treslin immunoprecipitates were
compared for levels of coprecipitated TopBP1 as a surrogate for treslin S1000 phos-
phorylation, as validated in Fig. 7. We felt that this was a more accurate way to measure
relative treslin phosphorylation, since TopBP1 and treslin ratios were determined from
the same immunoprecipitate. For control HeLa cells, thymidine treatment led to an
almost 50% decrease in TopBP1 binding, consistent with dephosphorylation of treslin
in response to the replication stress checkpoint. However, for HeLa cells overexpressing
Cks2, no decrease in TopBP1 binding in response to thymidine treatment was observed
(P  0.0015 comparing thymidine-treated samples using single-tailed t test) (Fig. 8),
consistent with override of the replication stress checkpoint in these cells. Indeed, Cks2
overexpression leads to an increase in TopBP1 binding upon replication stress, which
correlates with an increase in origin activation observed under these conditions (34). If
CDK binding is not required to enhance treslin phosphorylation, then overexpression of
a mutant CKS protein deﬁcient in CDK binding should similarly override the replication
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stress checkpoint by maintaining treslin phosphorylation. Indeed, overexpression of
Cks2 E63Q overrides the replication checkpoint (Fig. 9A) and maintains treslin phos-
phorylation, as indicated by TopBP1 binding (Fig. 9B), similar to wild-type Cks2 (P 
0.02 for comparisons of thymidine-treated samples using single-tailed t test), conﬁrm-
ing that canonical Cdk2 binding is not required for stimulation of treslin phosphory-
lation in cells.
Cks1/2 induction correlates with and is required for checkpoint recovery. We
hypothesized that Cks1/2-mediated override of the replication stress checkpoint is
relevant to checkpoint adaptation or recovery. Consistent with this, we observed that
Cks1/2 mRNA and protein levels increased rapidly upon removal of thymidine (2 h)
even before observable progression through S phase had occurred (Fig. 10A and B).
More signiﬁcantly, silencing of Cks1 and Cks2 rendered cells incapable of recovering
from the replication stress checkpoint (Fig. 11A). On the other hand, overexpression of
Cks2 promoted more rapid recovery from the checkpoint, as cells could be observed
progressing through S phase even at the 2-h time point (Fig. 11B).
DISCUSSION
CKS proteins as cofactors for treslin phosphorylation. Roles have been described
previously for CKS proteins as adaptors that link CDKs to substrates (6, 7). In particular,
the ability of CKS proteins to bind phosphates suggests a mechanism whereby a CKS
protein, by tethering a CDK to an already phosphorylated protein, can promote the
processive phosphorylation of additional nearby sites. Although the current study does
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not preclude such a mechanism for treslin, which contains numerous potential CDK
phosphorylation sites, it suggests an additional novel mechanism for treslin S1000
phosphorylation, the key site for origin ﬁring. Based on experiments with a treslin-
derived peptide containing the S1000 site, non-CDK-bound CKS protein can promote
CDK-dependent phosphorylation. However, the data presented are not consistent with
a simple model where CKS protein binds to treslin prior to engagement by the kinase.
Speciﬁcally, the weak binding of CKS protein to treslin in the absence of Cdk2 is
inconsistent with the EC50 of CKS protein-dependent stimulation of treslin phosphor-
ylation. We therefore propose two potential models. In the ﬁrst, treslin ﬁrst engages
Cdk2 to form a low-afﬁnity complex that is inefﬁcient for phosphorylation (Fig. 12A). In
this complex, however, treslin is remodeled to form the actual target of CKS protein
binding, converting it to a high-afﬁnity complex that is efﬁcient for phosphorylation
(Fig. 12A). In the second model, CKS proteins serve as noncanonical adapters by
binding to both Cdk2 and treslin in a manner not previously described (5) and requiring
different contact residues (Fig. 12B). This mechanism would be similar to the adapter
function for Cks1 observed for binding of the ubiquitin ligase substrate-binding subunit
Skp2 to the CDK inhibitor p27Kip1 (11, 12). Both of these models are consistent with a
number of observations. (i) CKS protein mutants shown to be incapable of CDK binding
can still stimulate S1000 phosphorylation, indicating that the previously described
canonical “adapter” function can be excluded. (ii) CKS proteins are capable of stimu-
lating phosphorylation of an 8-residue peptide containing the S1000 site. An interac-
tion between CKS protein and Cdk2, as structurally determined, is not compatible with
a simultaneous interaction between CKS protein and the substrate peptide bound to
the active site of Cdk2 (5). (iii) However, CKS proteins bind only weakly to free treslin
peptide. (iv) On the other hand, CKS proteins alter the Km for treslin phosphorylation.
We therefore speculate that the role of CKS protein in this context is to produce a
high-afﬁnity complex conducive to efﬁcient phosphorylation by Cdk2, although the
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data at this point cannot distinguish between the CKS protein binding site consisting
of treslin residues or a combination of treslin and Cdk2 residues (Fig. 12).
CKS proteins and override of the replication stress checkpoint. Cells overex-
pressing Cks1 or Cks2 fail to stop origin ﬁring when the replication stress checkpoint is
triggered, leading to continued progression through S phase (34). Nevertheless, the
replication stress signaling pathway was shown to be intact, with no defect in the
inhibitory phosphorylation of Cdk2 on Y15. However, based on our studies, treslin
continues to be phosphorylated, presumably by Cdk2. Two possible mechanisms could
FIG 11 Flow-cytometric analysis of control HeLa cells, HeLa cells silenced for Cks1 and Cks2 (A), and HeLa cells stably overexpressing
Cks2 treated with 2 mM thymidine for 24 h and then released for the indicated times from the thymidine block (B). The abscissa
represents DNA content and the ordinate represents the number of cells.
FIG 12 Potential mechanisms of CKS protein-dependent stimulation of treslin phosphorylation. (A) Cdk2
forms a low-afﬁnity, inefﬁcient complex with treslin. However, this binary complex forms a binding site
for CKS proteins on treslin that converts it to a high-afﬁnity complex that is efﬁcient for phosphorylation.
(B) CKS proteins are noncanonical adapters that bind both Cdk2 and treslin to produce a high-afﬁnity
complex efﬁcient for phosphorylation. This would be similar to the adapter role that Cks1 plays in linking
Skp2 to p27Kip1.
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account for this observation. CKS protein could serve to improve treslin as a substrate
for Y15-phosphorylated Cdk2. Alternatively, the ability of residual nonphosphorylated
Cdk2 to phosphorylate treslin could be enhanced by CKS protein binding. We favor
the latter explanation, as the crystallographically determined structure of Y15-phos-
phorylated Cdk2 is not compatible with the ability to accommodate a protein substrate
in the active-site groove (47). Indeed, it is evident that even when checkpoint signaling
is active, the steady state of Y15 phosphorylation of Cdk2 is considerably less than
100%, as Cdk2 kinase activity is easily detectable (34, 48). If CKS protein saturation can
increase the efﬁciency of S1000 phosphorylation 10- to 20-fold, then only a small
fraction of Cdk2 would need to be active to maintain treslin in a phosphorylated state.
The role of CKS-dependent checkpoint override. Cks1 and/or Cks2 are frequently
overexpressed in a broad spectrum of human malignancies, and we have shown that
the replication stress checkpoint cannot block DNA replication in cell lines derived from
such cancers (34). Therefore, we have speculated that CKS protein overexpression is
selected to evade oncoprotein-induced replication stress. However, this cannot be the
evolutionarily selected role for CKS protein-dependent checkpoint override. In the
current study, we show that Cks1 and Cks2 expression is signiﬁcantly increased
immediately upon reversal of replication stress and that silencing of Cks1 and Cks2
prevents recovery from the checkpoint and resumption of DNA replication, suggesting
that CKS protein-mediated checkpoint override has a role in facilitating recovery.
MATERIALS AND METHODS
Cell lines and cell culture. HeLa cells were programmed to overexpress Cks1 or Cks2 by transduc-
tion with recombinant retroviruses (pBABE-puro-Cks1 or Cks2) (34) or, in the case of Cks2 E63Q,
recombinant adenoviruses (34). In the case of Cks2 E63Q, adenoviral transduction was necessary to
achieve overexpression similar to retrovirally mediated expression of Cks2. Retroviral controls were cells
transduced with empty vector. All experiments were carried out with mixed populations of transduced
cells. Cells were plated onto 15-cm plates (Corning Inc.) at 5  106 cells/plate for 24 h in Dulbecco’s
modiﬁed Eagle’s medium (DMEM). For silencing experiments, cells were treated with short interfering
RNA (siRNA) oligonucleotides targeting green ﬂuorescent protein (GFP), Cks1, Cks2, or Cks1 and Cks2 for
24 h before harvesting. For replication stress experiments, cells were treated with 2 mM thymidine for
1 h before harvesting. For experiments where cells were transduced with recombinant adenovirus,
transductions were carried out 24 h prior to harvest. Once pelleted, cells were lysed in NP-40 lysis buffer
(49) with 2 the manufacturer’s recommended concentration of protease and phosphatase inhibitors
(Roche cOmplete protease inhibitor cocktail and PhoSTOP phosphatase inhibitor cocktail). Protein
concentration was determined via the Bradford protein assay (Bio-Rad).
Fluorescence-activated cell sorter (FACS) analysis. Cells were plated in 10-cm plates (Corning Inc.)
at 6  105 per plate for 24 h. Once harvested, cells were ﬁxed overnight in a 70:30 ethanol-phosphate-
buffered saline (PBS) solution. After overnight ﬁxation, cells were pelleted and permeabilized in 1 ml of
1% bovine serum albumin (BSA)–0.5% Tween 20–PBS. RNase solution was made by boiling 10 mg of
RNase in 1 ml of 15 mM NaCl–50 mM Tris solution for 15 min. One milliliter of RNase solution was
combined with 9 ml of PBS–0.1% Triton X-100 and 200 l of 10 mg/ml propidium iodide. After the cells
were pelleted by centrifugation, pellets were resuspended in propidium iodide staining solution and
incubated at room temperature for 2 h before ﬂow-cytometric analysis (NovoCyte; ACEA Biosciences).
Data analysis was carried out using FlowJo v.10.1.
Recombinant proteins. Puriﬁcation of CKS proteins and GST-treslin peptide fusions has been
described previously (40, 50). Active 6His-cyclin E-Cdk2 was puriﬁed from an E. coli strain expressing
yeast Cak1 (43) by nickel chelate chromatography followed by gel ﬁltration chromatography.
Quantitative real time-PCR analysis (qRT-PCR). Control and Cks1/2-overexpressing HeLa cells were
plated on 15-cm plates (Corning Inc.) at 5  106 cells for 24 h. Cells were transfected with siRNA
oligonucleotides targeting GFP, Cks1, Cks2, or Cks1 and Cks2 (Qiagen) at a concentration of 10 nM for
24 h using Lipofectamine RNAiMax (Life Technologies). RNAs were harvested using RNeasy minikit
columns (Qiagen). RNA (20 ng/l) was reversed transcribed, ampliﬁed, and quantiﬁed using PerfeCTa
Sybr green Supermix (Quanta BioSciences). Each sample was run in octuplicates. Expression levels were
determined relative to the control mRNA CDK2 using the formula 2CT(control mRNA)  CT(mRNA of interest) 
10,000, where CT is the threshold cycle. Standard deviations (SD) of the relative expression values were
calculated. Primers were obtained from Integrated DNA Technology. Primers were the following: CDK2,
5= GTTGAGGAACTGAGATGCGG 3= (forward) and 5= TTGTTCTTGGATGTGGGGAG 3= (reverse); CKS1, 5=
CTGATGTCTGAATCTGAATGGAGG 3= (forward) and 5= TTTCTTTGGTTTCTTGGGTAGTGG 3= (reverse); CKS2,
GAAGAGGAGTGGAGGAGACTT (forward) and 5= GTTGATCTTTTGGAAGAGGTCGT 3= (reverse).
In vitro kinase assays. Reaction mixtures of 30 l consisted of 17 nM activated Cdk2/CycE puriﬁed
from E. coli, 1.1 M GST-treslin, and the indicated concentrations of CKS protein and were incubated in
kinase buffer (20 mM Tris-HCl [pH 7.5], 2.5 mM MgCl2, 1 mM dithiothreitol [DTT], 250 M ATP) at 37°C
for 1 h. Reactions were quenched by addition of SDS-PAGE sample buffer and heating.
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Thermal shift assays. Thermal shift assays in 20 l of kinase buffer contained 10 M Cks1 alone or
Cks1 and treslin (997-1008) peptide at concentrations ranging from 10 M to 25 M. SyproOrange dye
was diluted 8 from the stock provided by the manufacturer (Applied Biosystems) in the protein thermal
shift dye kit. Reactions were carried out in octuplicate in a 96-well plate. Reaction mixtures were ﬁrst
incubated at 4°C for 1 h, and then a Bio-Rad CFX Connect qRT-PCR thermocycler was programmed for
0.5°C steps from 25°C to 95°C. After each step the ﬂuorescence emission was read to generate a melt
curve. The maximum value of the derivative of the melt curve (dRFU/dT) was taken as the melting
point (Tm).
Determination of Kms for treslin phosphorylation. To determine the Km for treslin phosphoryla-
tion, GST-treslin (989-1011) at increasing concentrations was incubated with cyclin E-Cdk2 at 17 nM
under conditions described above for kinase reactions. Reaction mixtures contained either no CKS
protein or 25 M Cks1 or Cks2. Reactions were analyzed by SDS-PAGE and Western blotting. However,
a number of modiﬁcations were made to improve quantiﬁcation. Gels were loaded such that equal
amounts of GST-treslin were in each lane so that transfer artifacts, such as membrane saturation, were
avoided. Signals were then deconvolved to give a ﬁnal adjusted value. After incubation of membranes
with antiphosphotreslin (S1000) antibody, quantiﬁcation was carried out using a Li-Cor Odyssey infrared
imager set so that all readings were in the linear range, rather than using ﬁlm, which generally is not linear.
Data were plotted and analyzed using GraphPad Prism curve-ﬁtting software. Each experiment was com-
posed of duplicate samples at each treslin concentration, and each experiment was carried out twice.
Mass spectrometry. The peptides were infused directly into an LTQ-Orbitrap mass spectrometer
(ThermoFisher Scientiﬁc) using electrospray ionization (ESI) at about 500 nl/min. To record m/z values for
intact peptides, the instrument was scanned at a resolution of 60,000 for about 10 min. Tandem MS data
were collected for m/z values at 770.3 and 810.3, representing the unmodiﬁed and modiﬁed peptide,
respectively.
Antibodies. Primary antibodies were obtained from the following sources: Cks1/2 (FL-79; Santa Cruz
Biotechnology), treslin and serine 1000-phosphorylated treslin (40, 46), Chk1 (26105; Cell Signaling
Technology), serine 345-phosphorylated Chk1 (13303; Cell Signaling Technology), cyclin A (H432; Santa
Cruz Biotechnology), cyclin E1 (E12; Santa Cruz Biotechnology), Cdk2 (M2; Santa Cruz Biotechnology),
TopBP1 (A300-111A; Bethyl Laboratories), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (3781;
ProSci), and ribosomal protein S6 (5610; Cell Signaling Technology). For Western blotting, all antibodies
were used at 1:1,000. Horseradish peroxidase (HRP)-conjugated anti-mouse and anti-rabbit secondary
antibodies were from Jackson Laboratories and used at 1:2,500. For immunoprecipitation experiments,
1.5 g of either treslin or phospho-S1000 treslin antibody was used per sample, and HRP-conjugated
protein A (Clean-Blot; Thermo Scientiﬁc) was used instead of a second antibody.
Immunoprecipitation, electrophoresis, and blotting. Once adjusted to equal concentrations, cell
lysates were immunoprecipitated in the presence of 50 g/ml ethidium bromide for 3 h with anti-human
treslin or antitreslin pS1000 antibody. Immune complexes were recovered by incubation with protein A
Dynabeads (Life Technologies) for 1 h. After incubation, beads were washed three times with NP-40
buffer containing 2 the manufacturer’s recommended concentration of protease and phosphatase
inhibitors (Roche cOmplete protease inhibitor cocktail and PhoSTOP phosphatase inhibitor cocktail), and
proteins then were eluted by incubation in SDS-PAGE sample buffer for 10 min at 65°C. For immuno-
blotting, lysates were separated on precast gradient SDS-PAGE gels (Life Technologies) and transferred
to a nitrocellulose or polyvinylidene diﬂuoride (PVDF) membrane using an iBlot gel transfer device (Life
Technologies). After blocking in 5% (wt/vol) milk made in 1 TBS-Tween 20 for 1 h at room temperature,
the membranes were incubated with primary antibody overnight at 4°C, washed, and incubated with
HRP-conjugated secondary antibodies for 1 h at room temperature. Blots were developed using ECL
technology. Quantiﬁcation of ﬁlms was carried out using ImageJ.
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